Roche developed an alternative to the office building planned
is maintained in order to gather all the jobs in Basel at the headquarters campus
Roche has decided to resign due to technical reasons the implementation in the manner provided in the office building announced. In the course of the development project has revealed that, despite heavy investment, would not meet functional needs paramount. In addition, operation and maintenance of the planned construction would be very expensive. Roche's intention remains to gather in the grounds of the headquarters of more than 1,700 jobs currently scattered in various parts of Basel. To this end, will now be preparing an alternative plan, maintaining, however, the timing of the work.
"It was not easy making this decision," said Franz B. Humor, Chairman of the Board of Directors of Roche. "Now, all our projects must resist the dessert a comprehensive business analysis. This does not detract in any way the value of the professional work of all those involved in planning the building, which deserves greater recognition. "
Meanwhile, Severin Schwan, chief executive officer (CEO) of Roche, said: "After an intensive study of the project, we concluded that the planned office building was, yes, technically feasible, but could not meet all our functional requirements. The many experiences of the team now inure to the benefit of alternative project" .
The presentation of the project for the office building had been set announced for the second quarter of 2009. Given the size of the project, Roche had consciously focused on it at a very early-autumn 2006 - to employees, neighbors, the city of Basel and other stakeholders. During development work it became clear that the planned construction could not meet important requirements. For example, would have had to give up the execution of an auditorium for 500 people and several central meeting rooms. Roche developed an alternative plan. Along with the functional requirements is maintained in order to honor and continue the architectural heritage of Roche in Basel. Since founding the company, the architecture of Roche in Basel has expressed its corporate culture over 112 years.
Development Basel-based Roche compound
The current development of Roche Basel campus model, as in the past, a planning concept that guarantees maximum flexibility, allowing adaptation to changing space needs the company. The plan calls for placing international and corporate functions of the Group primarily south of the Grenzacherstrasse, and units for research, development and production, which require special equipment, "north of it. In all buildings New, Roche values, along with operational requirements, continuity of its popular high-quality industrial architecture in a special way.
Roche Roche Headquartered in Basel (Switzerland) is a leading international health sector in the fields of pharmaceuticals and diagnostics research-focused. As the world's biggest biotech company and an innovator of products and services for early detection, prevention, diagnosis and treatment of diseases, the Roche Group contributes to improved health and quality of life of people. Roche is the leading global provider in vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36,800 million francs, and the Diagnostics Division, to 9,300 million. Roche has agreements with numerous partners and strategic alliances, among them majority ownership interests in Genentech and Chugai, and invested in 2007 more than 8,000 billion Swiss francs in R & D. Roche has 80,000 employees, in round figures. More information www.roche.com.
All trademarks mentioned in this release are protected by law.
0 comments:
Post a Comment